Alzheimer's Disease and Dementia
Aducanumab, Lecanemab for Early AD: The Clinical Trials That Led to FDA Approval
- Cluster Headache More Likely to Be Severe, Debilitating for Women Than Men
- Current, Former Smokers With MS Likely to Experience Depression and Anxiety
- Antibody Oligonucleotide Conjugate Fast Tracked for Facioscapulohumeral Muscular Dystrophy
- Moderna’s mRNA Vaccine Candidate Prevents RSV-Associated Disease in Older Adults
- Premature Cardiovascular Disease Linked to Lower Cognition
- Cognitive Screening Test at License Renewal Explored for Seniors
- Extracorporeal CPR Does Not Offer More Favorable Neurologic Outcome
- Sleep Medication Used by 8.4% of Adults in 2020
- Rate of Young Children Exposed to Edible Cannabis Grows Alarmingly
- COVID-19 Vaccine Timing After Rituximab Can Decrease Hospitalization in MS
- Ocular Hypertension Risk Elevated in Patients With Cushing Disease
- The State of Mental Health Smartphone Apps
Conference Coverage
MORE MEETINGS
Clinical Tools
Powered by
Powered by 
